Clinical Trials Directory

Trials / Completed

CompletedNCT06874023

Study to Warm Up and Cool Down Recreationally Active Males Using Different Protocols.

Warm Up and Cool Down Study: Various Combined Active and Passive Isothermic Heating Protocols, Followed by Different Cooling Protocols, to Increase and Lower Body Core Temperature.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Arizona State University · Academic / Other
Sex
Male
Age
18 Years – 30 Years
Healthy volunteers
Not accepted

Summary

The objective of this study was to examine the impact of four single-bout heating and cooling strategies on warming up and cooling down core body temperature. Heating strategies included: Passive heating in a hot environment (60 min), Active heating (30 min) + passive heating (30 min) in a hot environment, Active heating(60 min) in a hot environment, and Active heating (60 min) at room temperature. Cooling strategies to reduce body core temperature to baseline included: Cool vest (18°C) , Damp neck towel (24°C) combined with arm (i.e. hand, forearm and half of upper arm) cool water immersion (15°C), Combination of both, A control with participant sitting in a thermoneutral room (20°C air temperature) without any additional cooling intervention.

Detailed description

This semi-randomized crossover control trial was performed between September and October 2020. Data collection took place over the course of 5-weeks with 10 subjects, with one data collection session with all subjects per week (hence, 40 trials total). Baseline gastrointestinal temperature (Tgi) was recorded, and the final Tgi at the end of the heating intervention (Part I), was used as the starting temperature for the current study (Part II). Part I focused on assessing the efficacy of different heating strategies (Passive heating in a hot environment (60 min), Active heating (30 min) + passive heating (30 min) in a hot environment, Active heating(60 min) in a hot environment, and Active heating (60 min) at room temperature), aiming to reach a core temperature of 38.5°C during a 60-minute period. Part II focused on cooling the body to a pre-exercise baseline core temperature. Cooling strategies consisted of: 1) Cool vest (18°C) with 500 mL (16 fl oz) ice water consumption, 2) Damp neck towel (24°C) combined with arm (i.e. hand, forearm and half of upper arm) cool water immersion (15°C) and 500 mL (16 fl oz) ice water consumption 3) Combination of cool vest (18°C), damp neck towel (24°C) with arm cool water immersion (15°C), and 500 mL (16 fl oz) ice water consumption or 4) A control with participant sitting in a thermoneutral room (20°C air temperature) without any additional cooling intervention. Thermoneutral water was consumed ad libitum for all interventions in addition to the 500 mL (16 fl oz) ice water consumption for experimental trials (#1-3).

Conditions

Interventions

TypeNameDescription
OTHERPassive heating in hot conditionsParticipants performed seated passive heating in 54C conditions
OTHERActive heating + passive heating in hot conditionsParticipants performed 30 minutes of biking exercise in 43C + 30 min of passive seated heating in 54C conditions.
OTHERActive heating in hot conditionsParticipants performed 60 minutes of biking exercise in 43C.
OTHERActive heating at room temperatureParticipants performed active heating through biking exercise for 60 minutes at room temperature.
OTHERCool vestCool vest (18°C) with 500 mL (16 fl oz) ice water consumption
OTHERDamp neck towel combined with arm cool water immersionDamp neck towel (24°C) combined with arm (i.e. hand, forearm and half of upper arm) cool water immersion (15°C) and 500 mL (16 fl oz) ice water consumption
OTHERCombination of cooling interventionsCombination of cool vest (18°C), damp neck towel (24°C) with arm cool water immersion (15°C), and 500 mL (16 fl oz) ice water consumption
OTHERControl in thermoneutral room without coolingA control with participant sitting in a thermoneutral room (20°C air temperature) without any additional cooling intervention.

Timeline

Start date
2020-09-14
Primary completion
2020-10-23
Completion
2020-10-23
First posted
2025-03-13
Last updated
2025-03-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06874023. Inclusion in this directory is not an endorsement.